Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2101152	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-10-22		Novo Nordisk A/S			view
JYSB1700223	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2017-12-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2018-01-10	view
CXSL2200318	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-25		Tonghua Dongbao Pharmaceutical Co Ltd			view
CXSL1900144	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(10)	New Drug Application	2019-12-31	重庆宸安生物制药有限公司	ChongQing Chenan Biopharmaceutical Co Ltd	In Review	2019-12-30	view
JYSB2101166	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10		Novo Nordisk A/S			view
CXSL1600073	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(7)	New Drug Application	2016-10-08	海正药业（杭州）有限公司	Hisun Pharmaceutical (Hangzhou) Co Ltd	Certificate Issued	2017-12-21	view
JYSB2200187	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29		Novo Nordisk A/S			view
CXSL1900062	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(10)	New Drug Application	2019-07-04	珠海联邦制药股份有限公司	Zhuhai United Laboratories Co Ltd	In Review	2019-07-03	view
CXSL2300433	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2023-06-27		Wanbang Biopharmaceuticals			view
JYSB2101167	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10		Novo Nordisk A/S			view
JXSL1300028	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Import Drug Application	2013-04-17	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2015-08-07	view
CXSS2200066	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-15		Jilin Huisheng Biopharmaceutical Co Ltd			view
JYSB1900259	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2019-09-18	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-04-21	view
CXSS2400110	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2024-10-12		Zhuhai Federal Biomedical Co Ltd			view
CXSL2200319	德谷胰岛素注射液	insulin degludec	Injection	Biological Products(3.3)	New Drug Application	2022-07-25		Tonghua Dongbao Pharmaceutical Co Ltd			view
JXSS1500010	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Import Drug Application	2015-09-24	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2017-09-27	view
CYSB2101269	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2021-11-10		Novo Nordisk (China) Pharmaceuticals Co Ltd			view
JYSB1800140	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2018-07-30	诺和诺德（中国）制药有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Certificate Issued	2018-10-09	view
JYSB2200188	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-29		Novo Nordisk A/S			view
CYSB2200226	德谷胰岛素注射液	insulin degludec	Injection	Biological Products	Supplementary Application	2022-09-15		Novo Nordisk (China) Pharmaceuticals Co Ltd			view